Kalypsys is a San Diego based biopharmaceutical company with clinical stage pharmaceutical products. Central to our pipeline expansion is epiK™ – a proprietary and highly automated small molecule drug discovery platform.
epiK™ is the seamless integration of a powerful discovery Engine and a motivated team of talented People that enables Innovation in drug discovery and development at Kalypsys.
ON TARGET
epiK™ powers Saturation Discovery, an intensive, parallel examination of multiple targets in a disease pathway or mechanism. Saturation Discovery rapidly identifies the target and lead compound with the greatest potential to provide clinical success. epiK™
PARTNERSHIPS THAT PROMOTE SUCCESS
We sincerely value the opportunity to work collaboratively with partners to discover and advance next generation medicines. We recognize the importance of partnerships that leverage the power of epiK™. Please visit our Partnering page for additional information or contact Jackie Gulick at jgulick@kalypsys.com to discuss. Partnering
The ability to query relevant biological space with epiK™ offers insights and drug discovery opportunities that drive our pipeline and the pipelines of our strategic partners.